Product Information
COLD-SINUS 200 MG-30 MG CAPLET is a generic product labeled by Cardinal Health, priced at $0.1517 per EA under NDC 70000060201. Its NADAC has been published 175 times since Nov 2, 2022.
FDA first approved this application on Apr 17, 2001.
Strength
200; 30 mg/1; mg/1
Manufacturer
Cardinal HealthNDC
70000060201
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
10/22/2025
Active Ingredients
IBUPROFEN; PSEUDOEPHEDRINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA074567FDA Approved
4/17/2001
On Market Since
5/23/2022
Pharmacological Classes
Price Statistics
The NADAC for COLD-SINUS 200 MG-30 MG CAPLET has been published 175 times since Nov 2, 2022, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1517 per EA |
|---|---|
| All-time high | $0.1540 (Dec 14, 2022) |
| All-time low | $0.1497 (Dec 21, 2022) |
| 52-week high | $0.1517 |
| 52-week low | $0.1515 |
| Median price | $0.1512 |
| Average price | $0.1513 |
| Largest weekly change | -2.8% (Dec 21, 2022) |
| Weeks tracked | 175 |
| Tracking since | Nov 2, 2022 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
+0.2%
3Y
-0.1%
5Y
N/A
All
-1.5%
Last surveyed Mar 4, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the IBUPROFEN and PSEUDOEPHEDRINE HYDROCHLORIDE market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Cardinal Health manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
IBUPROFEN and PSEUDOEPHEDRINE HYDROCHLORIDE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Nonsteroidal Anti-inflammatory Drug class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of COLD-SINUS 200 MG-30 MG CAPLET?
The current National Average Drug Acquisition Cost (NADAC) for COLD-SINUS 200 MG-30 MG CAPLET, manufactured by Cardinal Health, is $0.1517 per EA (NDC 70000060201), effective Mar 4, 2026.
How has the price of COLD-SINUS 200 MG-30 MG CAPLET changed over time?
Over the history we have for it, the NADAC for COLD-SINUS 200 MG-30 MG CAPLET has held within roughly two percent of its current level. It has been tracked across 175 weekly CMS publications since Nov 2, 2022.
What are the highest and lowest recorded NADAC prices for COLD-SINUS 200 MG-30 MG CAPLET?
Since Nov 2, 2022, the NADAC for COLD-SINUS 200 MG-30 MG CAPLET has ranged from a low of $0.1497 (Dec 21, 2022) to a high of $0.1540 (Dec 14, 2022), with a median of $0.1512 per EA.
Are there cheaper alternatives to COLD-SINUS 200 MG-30 MG CAPLET?
No other NADAC-published product currently shares the active ingredient and strength of COLD-SINUS 200 MG-30 MG CAPLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures COLD-SINUS 200 MG-30 MG CAPLET?
COLD-SINUS 200 MG-30 MG CAPLET (NDC 70000060201) is labeled by Cardinal Health, and CMS classifies it as a generic product.